View:
SafeStitch
Medical, Inc.
4400
Biscayne Boulevard
Suite
A-100
Miami,
Florida 33137
July 2,
2009
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100 F
Street, N.E.
Washington,
D.C. 20549
|
Re:
|
SafeStitch
Medical, Inc. Post Effective Amendment No. 1 to Registration Statement on
Form S-8 (File No. 333-08049)
|
Dear
Ladies and Gentlemen:
Reference
is made to the Post Effective Amendment No. 1 to Registration Statement on Form
S-8 (File No. 333-08049) filed with the Securities and Exchange Commission (the
“Commission”)
by SafeStitch Medical, Inc., a Delaware corporation (the “Company”), on March
24, 2009 (the “Post
Effective Amendment”). Pursuant to Rule 477 promulgated under the
Securities Act of 1933, as amended, the Company hereby applies for the immediate
withdrawal of the Post Effective Amendment.
The Post
Effective Amendment was incorrectly filed with the EDGAR header “POS AM” instead
of the correct EDGAR header, “S-8 POS”. Promptly following the withdrawal of the
Post Effective Amendment, the Company intends to file with the Commission a
substantially identical post effective amendment containing the header “S-8
POS”.
If you
have questions or require additional information, please do not hesitate to
contact the Company’s outside counsel, Robert L. Grossman, Esq. of Greenberg
Traurig P.A. at (305) 579-0500.
|
Sincerely,
SAFESTITCH
MEDICAL, INC.
By: /s/ Adam S.
Jackson
Name:
Adam S. Jackson
Title:
Chief Financial Officer
|